Stocks
Nektar Therapeutics (NKTR) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -461.8 | -323.9 | -243.1 | -86.7 | -137.0 | -120.1 | ||
| Changes by years, y/y, % | +17% | -30% | -25% | -64% | +58% | -19.1% | |||
Nektar Therapeutics. EBITDA US GAAP, bln rub
Nektar Therapeutics. EBITDA US GAAP, changes, %
Nektar Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Nektar Therapeutics (NKTR) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -29.3 | -26.1 | -36.7 | -63.9 | -42.2 | -120.1 | |
| Changes by years, y/y, % | -2% | -249% | -10% | +89% | +25% | |||
| Changes by quarters, q/q, % | -13% | -11% | +41% | +74% | -34% | |||
